Interventional Cardiology Market Size, Share & COVID19 Impact Analysis - Global - 2023-2029 - MedSuite - Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more
Description
Interventional Cardiology Market Size, Share & COVID19 Impact Analysis - Global - 2023-2029 - MedSuite - Includes: Coronary Stent Market, Coronary Balloon Catheter Market and 10 more
In 2022, the Global Interventional Cardiology Market was valued at $11 billion. Over the forecast period, it is projected to grow at a CAGR of 2.4% and reach $13 billion.
The comprehensive report suite on the global interventional cardiology market includes various segments such as coronary stent, coronary balloon catheter, interventional coronary catheter, interventional coronary guidewire, coronary embolic protection device, atherectomy and intravascular lithotripsy (IVL) device, coronary introducer sheath, coronary vascular closure device (VCD), diagnostic catheter and guidewire, optical coherence tomography (OCT) catheter, and intravascular ultrasound (IVUS) catheter markets.
DATA TYPES INCLUDED
Unit Sales, Average Selling Prices, Market Size & Growth Trends
Interventional Cardiology Procedure Volumes
Market Forecasts Until 2029, and Historical Data to 2019
Market Drivers & Limiters for Each Global Interventional Cardiology market
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
COVID19 Impact on the Global Interventional Cardiology market
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL INTERVENTIONAL CARDIOLOGY MARKET INSIGHTS
Access to healthcare and the development of hospital infrastructure in developing countries across Latin America and Asia-Pacific, including China and India, have shown significant improvement. As a result, more individuals worldwide are able to undergo interventional procedures, leading to the expansion of the device market. The forecasted trend for the future indicates a continuous decline in prices, primarily influenced by market consolidation and bundling practices. With numerous competitors in the market, it has become common for devices to be bundled together at a lower price in order to boost overall sales. The utilization of intravascular imaging technologies varies across different regions worldwide. Currently, North America and Asia Pacific exhibit the highest adoption rates, demonstrating widespread usage of these devices. In contrast, other regions are experiencing a gradual yet steady increase in the implementation of this technology.
GLOBAL INTERVENTIONAL CARDIOLOGY MARKET SHARE INSIGHT
In 2022, three major players, namely Boston Scientific, Abbott, and Medtronic, dominated the global interventional cardiology market. Boston Scientific emerged as the leader in several segments, including coronary stents, balloon catheters, and embolic protection devices. The company's extensive range of devices, coupled with its international sales team, enabled it to maintain its dominant position.
Abbott excelled in the interventional coronary guidewire and OCT catheter markets, particularly in Western Europe. The Xience™ drug-eluting stent, known for its effectiveness in chronic total occlusion (CTO) cases, gained significant traction in terms of units sold.
Medtronic showcased its presence across multiple market segments, including coronary stents, balloon catheters, interventional coronary catheters, diagnostic catheters and guidewires, as well as embolic protection devices and coronary introducer sheaths. The company's notable performance was observed in the interventional coronary catheter market, where it offered product lines such as Launcher®, Sherpa NX™ Active, Sherpa NX™ Balanced, and Telescope™ under its portfolio.
REPORT GEOGRAPHIC COVERAGE
Throughout this research series, iData Research has extensively examined and analyzed several regions. The regions covered in our research include:
North America (United States and Canada)
Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
Central and Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
Africa( South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
DETAILED MARKET SEGMENTATION
While the MedSuite report provides comprehensive analysis and data for the Global Interventional Cardiology Devices market, we also offer individual MedCore reports for each market segment. This allows you to access specific market research that is relevant to your needs.
Coronary Stent Market – MedCore
Coronary Balloon Catheter Market – MedCore
Interventional Coronary Catheter Market – MedCore
Interventional Coronary Guidewire Market – MedCore
Coronary Embolic Protection Device Market – MedCore
Coronary Atherectomy & Intravascular Lithotripsy (IVL) Device Market – MedCore
Coronary Introducer Sheath Market – MedCore
Coronary Vascular Closure Device (VCD) Market – MedCore
Diagnostic Coronary Catheter & Guidewire Market – MedCore
Intravascular Ultrasound (IVUS) Market – MedCore
Coronary Optical Coherency Tomography Catheter Market – MedCore
RESEARCH SCOPE SUMMARY
Regions: North America (United States and Canada), Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other), Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other), Central & Eastern Europe (Serbia, Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other), Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other), Africa (South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.
WHY CHOOSE IDATA?
Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
Table of Contents
577 Pages
- executive summary
- Global Interventional Cardiology Device Market Overview
- Competitive Analysis
- Market Trends
- Market Developments
- Procedures Included
- Markets Included
- Regions Included
- Version History
- research methodology
- Step 1: Project Initiation & Team Selection
- Step 2: Prepare Data Systems and Perform Secondary Research
- Step 3: Preparation for Interviews & Questionnaire Design
- Step 4: Performing Primary Research
- Step 5: Research Analysis: Establishing Baseline Estimates
- Step 6: Market Forecast and Analysis
- Step 7: Identify Strategic Opportunities
- Step 8: Final Review and Market Release
- Step 9: Customer Feedback and Market Monitoring
- impact of covid-19 on THE global Interventional cardiology Market
- 2.1 Introduction
- 2.2 Regional Profiles
- 2.3 Analysis By Market Segment
- 2.3.1 Worst Case Scenario
- 2.3.2 Base Case Scenario
- 2.3.3 Best Case Scenario
- Disease Overview
- 3.1 Basic Anatomy
- 3.2 Disease Treatment and Diagnostic
- 3.2.1 General Diagnostics
- 3.2.2 Coronary Artery Disease
- 3.2.3 Myocardial Infarction
- 3.2.4 Angina Pectoris
- 3.3 Patient Demographics
- Product Assessment
- 4.1 Introduction
- 4.2 Product Portfolios
- 4.2.1 Coronary Stent Market
- 4.2.2 Coronary Balloon Catheter Market
- 4.2.3 Interventional Coronary Catheter Market
- 4.2.4 Interventional Coronary Guidewire Market
- 4.2.5 Coronary Embolic Protection Device Market
- 4.2.5.1 Saphenous Vein Grafts
- 4.2.5.2 Protection Mechanism
- 4.2.5.2.1 Filter Basket
- 4.2.5.2.2 Distal Balloon Occlusion
- 4.2.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market
- 4.2.7 Introducer Sheath Market
- 4.2.8 Coronary Vascular Closure Device Market
- 4.2.9 Diagnostic Coronary Catheter & Guidewire Market
- 4.2.10 Coronary Intravascular Ultrasound Market
- 4.2.11 Coronary Optical Coherence Tomography Market
- 4.3 Regulatory Issues and Recalls
- 4.3.1 Coronary Stent Market FDA Recalls
- 4.3.2 Coronary Balloon Catheter Market FDA Recalls
- 4.3.3 Interventional Coronary Catheter Market FDA Recalls
- 4.3.4 Interventional Coronary Guidewire Market FDA Recalls
- 4.3.5 Coronary Atherectomy and Intravascular Lithotripsy Device Market FDA Recalls
- 4.3.6 Coronary Introducer Sheath Market FDA Recalls
- 4.3.7 Coronary Vascular Closure Device Market FDA Recalls
- 4.3.8 Diagnostic Coronary Catheter & Guidewire Market FDA Recalls
- 4.3.9 Coronary Intravascular Ultrasound Market FDA Recalls
- 4.4 Clinical Trials
- 4.4.1 Coronary Stent Market Clinical Trials
- 4.4.2 Coronary Balloon Catheter Market Clinical Trials
- 4.4.3 Interventional Coronary Catheter Market Clinical Trials
- 4.4.4 Interventional Coronary Guidewire Market Clinical Trials
- 4.4.5 Coronary Embolic Protection Device Market Clinical Trials
- 4.4.6 Coronary Atherectomy and Intravascular Lithotripsy Device Market Clinical Trials
- 4.4.7 Coronary Vascular Closure Device
- 4.4.8 Coronary Intravascular Ultrasound
- 4.4.9 Coronary Optical Coherence Tomography
- Global Interventional cardiology Device Market Overview
- 5.1 Introduction
- 5.1.1 Population at Risk
- 5.2 Market Overview & Trend Analysis
- 5.2.1 By Segment
- 5.2.2 By Region
- 5.3 Drivers and Limiters
- 5.3.1 Market Drivers
- 5.3.2 Market Limiters
- 5.4 Competitive Market Share Analysis
- 5.5 Mergers and Acquisitions
- 5.6 Company Profiles
- 5.6.1 Abbott
- 5.6.2 Asahi Intecc
- 5.6.3 Boston Scientific
- 5.6.4 Cook Medical
- 5.6.5 Cordis
- 5.6.6 Medtronic
- 5.6.7 Penumbra
- 5.6.8 Philips
- 5.6.9 Teleflex
- 5.6.10 Terumo
- 5.7 SWOT Analysis
- 5.7.1 Abbott
- 5.7.2 Asahi Intecc
- 5.7.3 Boston Scientific
- 5.7.4 Cordis
- 5.7.5 Cook Medical
- 5.7.6 Medtronic
- 5.7.7 Penumbra
- 5.7.8 Philips
- 5.7.9 Teleflex
- 5.7.10 Terumo
- Coronary Stent Market
- 6.1 Executive Summary
- 6.1.1 Global Coronary Stent Market Overview
- 6.1.2 Competitive Analysis
- 6.1.3 Procedures Included
- 6.1.4 Markets Included
- 6.1.5 Regions Included
- 6.2 Introduction
- 6.3 Procedure Numbers
- 6.4 Market Overview
- 6.4.1 By Segment
- 6.4.2 By Region
- 6.5 Market Analysis and Forecast
- 6.5.1 Total Coronary Stent Market
- 6.5.2 Bare-Metal Stent Market
- 6.5.3 Drug-Eluting Stent Market
- 6.6 Drivers and Limiters
- 6.6.1 Market Drivers
- 6.6.2 Market Limiters
- 6.7 Competitive Market Share Analysis
- Coronary Balloon Catheter Market
- 7.1 Executive Summary
- 7.1.1 Global Coronary Balloon Catheter Market Overview
- 7.1.2 Competitive Analysis
- 7.1.3 Procedures Included
- 7.1.4 Markets Included
- 7.1.5 Regions Included
- 7.2 Introduction
- 7.3 Procedure Numbers
- 7.4 Market Overview
- 7.4.1 By Segment
- 7.4.2 By Region
- 7.5 Market Analysis and Forecast
- 7.5.1 Total Coronary Balloon Catheter Market
- 7.5.2 PTCA Balloon Catheter Market
- 7.5.3 Specialty Balloon Catheter Market
- 7.6 Drivers and Limiters
- 7.6.1 Market Drivers
- 7.6.2 Market Limiters
- 7.7 Competitive Market Share Analysis
- interventional coronary catheter Market
- 8.1 Executive Summary
- 8.1.1 Global Interventional Coronary Catheter Market Overview
- 8.1.2 Competitive Analysis
- 8.1.3 Procedures Included
- 8.1.4 Regions Included
- 8.2 Introduction
- 8.3 Procedure Numbers
- 8.4 Market Analysis and Forecast
- 8.5 Drivers and Limiters
- 8.5.1 Market Drivers
- 8.5.2 Market Limiters
- 8.6 Competitive Market Share Analysis
- Interventional Coronary guidewire Market
- 9.1 Executive Summary
- 9.1.1 Global Interventional Coronary Guidewire Market Overview
- 9.1.2 Competitive Analysis
- 9.1.3 Procedures Included
- 9.1.4 Regions Included
- 9.2 Introduction
- 9.3 Procedure Numbers
- 9.4 Market Analysis and Forecast
- 9.5 Drivers and Limiters
- 9.5.1 Market Drivers
- 9.5.2 Market Limiters
- 9.6 Competitive Market Share Analysis
- Coronary embolic protection device Market
- 10.1 Executive Summary
- 10.1.1 Global Coronary Embolic Protection Device Market Overview
- 10.1.2 Competitive Analysis
- 10.1.3 Regions Included
- 10.2 Introduction
- 10.2.1 Protection Mechanism
- 10.2.1.1 Filter Basket
- 10.2.1.2 Distal Balloon Occlusion
- 10.3 Market Analysis and Forecast
- 10.4 Drivers and Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
- 10.5 Competitive Market Share Analysis
- Atherectomy and Intravascular Lithotripsy Device Market
- 11.1 Executive Summary
- 11.1.1 Global Atherectomy and Intravascular Lithotripsy Device Market Overview
- 11.1.2 Competitive Analysis
- 11.1.3 Procedures Included
- 11.1.4 Regions Included
- 11.2 Introduction
- 11.3 Procedure Numbers
- 11.4 Market Analysis and Forecast
- 11.5 Drivers and Limiters
- 11.5.1 Market Drivers
- 11.5.2 Market Limiters
- 11.6 Competitive Market Share Analysis
- Coronary Introducer Sheath Market
- 12.1 Executive Summary
- 12.1.1 Global Coronary Introducer Sheath Market Overview
- 12.1.2 Competitive Analysis
- 12.1.3 Procedures Included
- 12.1.4 Regions Included
- 12.2 Introduction
- 12.2.1 Introducer Sheaths
- 12.2.2 Micro-Introducers
- 12.2.3 Catheter Insertion Approaches
- 12.2.3.1 Femoral Approach
- 12.2.3.2 Radial/Brachial Approach
- 12.3 Procedure Numbers
- 12.4 Market Analysis and Forecast
- 12.5 Drivers and Limiters
- 12.5.1 Market Drivers
- 12.5.2 Market Limiters
- 12.6 Competitive Market Share Analysis
- Coronary Vascular Closure Device Market
- 13.1 Executive Summary
- 13.1.1 Global Coronary Vascular Closure Device Market Overview
- 13.1.2 Competitive Analysis
- 13.1.3 Procedures Included
- 13.1.4 Markets Included
- 13.1.5 Regions Included
- 13.2 Introduction
- 13.2.1 Intravascular and Extravascular Devices
- 13.3 Procedure Numbers
- 13.4 Market Overview
- 13.4.1 By Segment
- 13.4.2 By Region
- 13.5 Market Analysis and Forecast
- 13.5.1 Total Coronary Vascular Closure Device Market
- 13.5.2 Invasive VCD Market
- 13.5.3 Non-Invasive VCD Market
- 13.6 Drivers and Limiters
- 13.6.1 Market Drivers
- 13.6.2 Market Limiters
- 13.7 Competitive Market Share Analysis
- Diagnostic Catheter and Guidewire Market
- 14.1 Executive Summary
- 14.1.1 Global Diagnostic Catheter and Guidewire Market Overview
- 14.1.2 Competitive Analysis
- 14.1.3 Procedures Included
- 14.1.4 Markets Included
- 14.1.5 Regions Included
- 14.2 Introduction
- 14.3 Procedure Numbers
- 14.3.1 Total Procedures
- 14.3.2 Angiography Procedures
- 14.3.3 FFR Guidewire Procedures
- 14.4 Market Overview
- 14.4.1 By Segment
- 14.4.2 By Region
- 14.5 Market Analysis and Forecast
- 14.5.1 Total Diagnostic Catheter and Guidewire Market
- 14.5.2 Interventional Diagnostic Catheter Market
- 14.5.3 Interventional Diagnostic Guidewire Market
- 14.5.4 FFR Guidewire Market
- 14.6 Drivers and Limiters
- 14.6.1 Market Drivers
- 14.6.2 Market Limiters
- 14.7 Competitive Market Share Analysis
- Optical Coherence Tomography Catheter Market
- 15.1 Executive Summary
- 15.1.1 Global Optical Coherence Tomography Catheter Market Overview
- 15.1.2 Competitive Analysis
- 15.1.3 Procedures Included
- 15.1.4 Regions Included
- 15.2 Introduction
- 15.2.1 OCT Applications
- 15.3 Procedure Numbers
- 15.4 Market Analysis and Forecast
- 15.5 Drivers and Limiters
- 15.5.1 Market Drivers
- 15.5.2 Market Limiters
- 15.6 Competitive Market Share Analysis
- Intravascular Ultrasound Catheter Market
- 16.1 Executive Summary
- 16.1.1 Global Intravascular Ultrasound Catheter Market Overview
- 16.1.2 Competitive Analysis
- 16.1.3 Procedures Included
- 16.1.4 Regions Included
- 16.2 Introduction
- 16.2.1 Pre-Stenting Applications
- 16.2.2 Post-Stenting Applications
- 16.3 Procedure Numbers
- 16.4 Market Analysis and Forecast
- 16.5 Drivers and Limiters
- 16.5.1 Market Drivers
- 16.5.2 Market Limiters
- 16.6 Competitive Market Share Analysis
- Abbreviations
- List of Charts
- Chart 1-1: Interventional Cardiology Market by Segment, Global, 2022 – 2029
- Chart 1-2: Interventional Cardiology Procedures, Global, 2022 & 2029
- Chart 2-1: Multi-Scenario Interventional Cardiology Market Forecast, Global, 2019 – 2029 (US$M)
- Chart 5-1: Interventional Cardiology Market by Segment, Global, 2019 – 2029
- Chart 5-2: Interventional Cardiology Market by Region, Global, 2019 – 2029
- Chart 5-3: Leading Competitors, Interventional Cardiology Market, Global, 2022
- Chart 6-1: Coronary Stent Market, Global, 2022 & 2029
- Chart 6-2: Angioplasty/PCI Procedures, Global, 2022
- Chart 6-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
- Chart 6-4: Coronary Stent Market by Segment, Global, 2019 – 2022
- Chart 6-5: Coronary Stent Market by Region, Global, 2019 – 2029
- Chart 6-6: Leading Competitors, Coronary Stent Market, Global, 2022
- Chart 7-1: Coronary Balloon Catheter Market, Global, 2022 & 2029
- Chart 7-2: Angioplasty/PCI Procedures, Global, 2022
- Chart 7-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
- Chart 7-4: Coronary Balloon Catheter Market by Segment, Global, 2019 – 2029
- Chart 7-5: Coronary Balloon Catheter Market by Region, Global, 2019 – 2029
- Chart 7-6: Leading Competitors, Coronary Balloon Catheter Market, Global, 2022
- Chart 8-1: Interventional Coronary Catheter Market, Global, 2022 & 2029
- Chart 8-2: Angioplasty/PCI Procedures, Global, 2022
- Chart 8-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
- Chart 8-4: Leading Competitors, Interventional Coronary Catheter Market, Global, 2022
- Chart 9-1: Interventional Coronary Guidewire Market, Global, 2022 & 2029
- Chart 9-2: Angioplasty/PCI Procedures, Global, 2022
- Chart 9-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
- Chart 9-4: Leading Competitors, Interventional Coronary Guidewire Market, Global, 2022
- Chart 10-1: Coronary Embolic Protection Device Market, Global, 2022 & 2029
- Chart 10-2: Coronary Embolic Protection Procedures, Global, 2022
- Chart 10-3: Leading Competitors, Coronary Embolic Protection Device Market, Global, 2022
- Chart 11-1: Atherectomy and IVL Device Market, Global, 2022 & 2029
- Chart 11-2: Atherectomy and IVL Procedures, Global, 2022
- Chart 11-3: Coronary Atherectomy and IVL Procedures by Region, Global, 2019 – 2029
- Chart 11-4: Leading Competitors, Coronary Atherectomy and IVL Device Market, Global, 2022
- Chart 12-1: Coronary Introducer Sheath Market, Global, 2022 & 2029
- Chart 12-2: Coronary Introducer Sheath Procedures, Global, 2022
- Chart 12-3: Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
- Chart 12-4: Leading Competitors, Coronary Introducer Sheath Market, Global, 2022
- Chart 13-1: Coronary Vascular Closure Device Market, Global, 2022 & 2029
- Chart 13-2: Coronary Vascular Closure Device Procedures, Global, 2022
- Chart 13-3: Catheterization Procedures by Region, Global, 2019 – 2029
- Chart 13-4: Coronary Vascular Closure Device Market by Segment, Global, 2019 – 2029
- Chart 13-5: Coronary Vascular Closure Device Market by Region, Global, 2019 – 2029
- Chart 13-6: Leading Competitors, Coronary Vascular Closure Device Market, Global, 2022
- Chart 14-1: Diagnostic Catheter and Guidewire Market, Global, 2022 & 2029
- Chart 14-2: Diagnostic Catheter and Guidewire Procedures, Global, 2022
- Chart 14-3: Angiography Procedures by Region, Global, 2019 – 2029
- Chart 14-4: FFR Guidewire Procedures by Region, Global, 2019 – 2029
- Chart 14-5: Diagnostic Catheter and Guidewire Market by Segment, Global, 2019 – 2029
- Chart 14-6: Diagnostic Catheter and Guidewire Market by Region, Global, 2019 – 2029
- Chart 14-7: Leading Competitors, Diagnostic Catheter and Guidewire Market, Global, 2022
- Chart 15-1: OCT Catheter Market, Global, 2022 & 2029
- Chart 15-2: OCT Catheter Procedures, Global, 2022
- Chart 15-3: OCT Procedures by Region, Global, 2019 – 2029
- Chart 15-4: Leading Competitors, OCT Catheter Market, Global, 2022
- Chart 16-1: IVUS Catheter Market, Global, 2022 & 2029
- Chart 16-2: IVUS Catheter Procedures, Global, 2022
- Chart 16-3: IVUS Procedures by Region, Global, 2019 – 2029
- Chart 16-4: Leading Competitors, IVUS Catheter Market, Global, 2022
- List of Figures
- Figure 1-1: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (1 of 2)
- Figure 1-2: Interventional Cardiology Market Share Ranking by Segment, Global, 2022 (2 of 2)
- Figure 1-3: Companies Researched in This Report (1 of 2)
- Figure 1-4: Companies Researched in This Report (2 of 2)
- Figure 1-5: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (1 of 2)
- Figure 1-6: Factors Impacting the Interventional Cardiology Device Market by Segment, Global (2 of 2)
- Figure 1-7: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (1 of 2)
- Figure 1-8: Recent Events in the Interventional Cardiology Device Market, Global, 2019 – 2023 (2 of 2)
- Figure 1-9: Interventional Cardiology Device Procedures Covered
- Figure 1-10: Interventional Cardiology Device Markets Covered
- Figure 1-11: Interventional Cardiology Device Market Regions Covered, Global (1 of 2)
- Figure 1-12: Interventional Cardiology Device Market Regions Covered, Global (2 of 2)
- Figure 1-13: Version History
- Figure 2-1: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)
- Figure 2-2: Interventional Cardiology Market by Segment, Worst Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)
- Figure 2-3: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)
- Figure 2-4: Interventional Cardiology Market by Segment, Base Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)
- Figure 2-5: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (1 of 2)
- Figure 2-6: Interventional Cardiology Market by Segment, Best Case Scenario, Global, 2019 – 2029 (US$M) (2 of 2)
- Figure 4-1: Coronary Stents by Company
- Figure 4-2: Coronary Balloon Catheters by Company
- Figure 4-3: Interventional Coronary Catheters by Company
- Figure 4-4: Interventional Coronary Guidewires by Company
- Figure 4-5: Coronary Embolic Protection Devices by Company
- Figure 4-6: Coronary Atherectomy and Intravascular Lithotripsy Devices by Company
- Figure 4-7: Coronary Introducer Sheaths by Company (1 of 2)
- Figure 4-8: Coronary Introducer Sheaths by Company (2 of 2)
- Figure 4-9: Coronary Vascular Closure Devices by Company
- Figure 4-10: Diagnostic Coronary Catheters & Guidewires by Company
- Figure 4-11: Coronary Intravascular Ultrasound Devices by Company
- Figure 4-12: Coronary Optical Coherence Tomography by Company
- Figure 4-13: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System
- Figure 4-14: Class 2 Device Recall XIENCE Sierra TM RX 3.5mm x 33mm
- Figure 4-15: Class 2 Device Recall Cordis Precise Nitinol Stent System
- Figure 4-16: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System
- Figure 4-17: Class 2 Device Recall Rebel Monorail PtCr Coronary Stent System
- Figure 4-18: Class 1 Device Recall NC TREK Coronary Dilatation Catheter
- Figure 4-19: Class 1 Device Recall NC TRAVLER Coronary Dilatation Catheter
- Figure 4-20: Class 2 Device Recall NC Emerge OverTheWire (OTW) and NC Emerge Monorail (MR) PTCA Dilatation Catheters
- Figure 4-21: Class 2 Device Recall Spectranetics AngioSculpt PTCA Scoring Balloon Catheter
- Figure 4-22: Class 2 Device Recall Solarice Rapid Exchange Balloon Dilatation Catheter
- Figure 4-23: Class 2 Device Recall Euphoria Rapid Exchange Balloon Dilatation Catheter
- Figure 4-24: Class 2 Device Recall MAMBA Flex 135 Microcatheter
- Figure 4-25: Class 2 Device Recall MAMBA Microcatheter
- Figure 4-26: Class 2 Device Recall Guidezilla II Guide Extension Catheter
- Figure 4-27: Class 1 Device Recall SHERPA NX ACTIVE GUIDING CATHETER
- Figure 4-28: Class 3 Device Recall Cordis Vista Brite Tip AdroitTM Guiding Catheter
- Figure 4-29: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters
- Figure 4-30: Class 1 Device Recall 6F Taiga Guiding Catheter
- Figure 4-31: Class 2 Device Recall Destination Guiding Sheath
- Figure 4-32: Class 2 Device Recall Stingray"" Guidewire
- Figure 4-33: Class 1 Device Recall TurboHawk Plus
- Figure 4-34: Class 1 Device Recall HawkOne
- Figure 4-35: Class 2 Device Recall Boston Scientific ROTAPRO
- Figure 4-36: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
- Figure 4-37: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER
- Figure 4-38: Class 2 Device Recall
- Figure 4-39: Class 2 Device Recall Flexor CheckFlo Introducer Raabe Modification
- Figure 4-40: Class 2 Device Recall Prelude Short Sheath Introducer
- Figure 4-41: Class 2 Device Recall Prelude SNAP Splittable Sheath Introducer
- Figure 4-42: Class 2 Device Recall Avanti Catheter Sheath Introducer
- Figure 4-43: Class 1 Device Recall Flexor CheckFlo Introducer
- Figure 4-44: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS
- Figure 4-45: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER
- Figure 4-46: Class 1 Device Recall Portico Solo ReCollapsible Access System
- Figure 4-47: Class 1 Device Recall SOLOPATH Balloon Expandable TransFemoral System
- Figure 4-48: Class 2 Device Recall Microintroducer Kit
- Figure 4-49: Class 2 Device Recall PreludeSYNC DISTAL Radial Compression Devices
- Figure 4-50: Class 2 Device Recall AngioSeal Evolution
- Figure 4-51: Class 1 Device Recall Imager II 5F Angiographic Catheter
- Figure 4-52: Class 1 Device Recall ACIST Kodama Intravascular Ultrasound Catheter
- Figure 4-53: Class 2 Device Recall iLab Polaris MultiModality Guidance System
- Figure 4-54: IonMAN Trial- First In Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System (IonMAN)
- Figure 4-55: RESOLUTE ONYX China Single Arm Study
- Figure 4-56: Abbott Next Generation Drug Eluting Stent 48mm Study (ABT NG DES 48)
- Figure 4-57: Study on Absorbable Zinc Alloy Drug Eluting Coronary Stent System
- Figure 4-58: PROMUS PREMIER™ China Post-Approval Study
- Figure 4-59: A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s)
- Figure 4-60: China Resolute Integrity 34/38 mm Study
- Figure 4-61: ILUMIEN IV: OPTIMAL PCI
- Figure 4-62: RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)
- Figure 4-63: RESOLUTE ONYX Post-Approval Study (ONYX PAS)
- Figure 4-64: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions (BIOFLOW-V)
- Figure 4-65: A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48)
- Figure 4-66: Sirolimus DEB in Coronary Bifurcation Lesions
- Figure 4-67: Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)
- Figure 4-68: Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions (PROMISE-BIF)
- Figure 4-69: Coronary Non-slip Balloon Catheter in Patients With Coronary Artery Stenosis (CREST)
- Figure 4-70: Clinical Trials of Pulsed Sonic Balloon Dilatation Catheter and Pulsed Sonic Generater
- Figure 4-71: TReAtmeNt of Small Coronary Vessels: MagicTouch Sirolimus Coated Balloon (TRANSFORM I)
- Figure 4-72: A Safety and Efficacy Study of Lepu® Drug Coated Balloon in Treatment of Coronary Small-vessel Disease
- Figure 4-73: ACOART Paclitaxel SVD: Paclitaxel Coated Coronary Balloon Catheter in Treatment of Coronary Small Vessel Diseases
- Figure 4-74: FIRE AND ICE II Trial Pilot
- Figure 4-75: Outcomes of Interventional Catheterization in Infants Less Than 3 Months With Critical Congenital Heart Disease (CHD)
- Figure 4-76: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation (STOP AF First)
- Figure 4-77: Chronic Total Occlusion Percutaneous Coronary Intervention Study (CTO-PCI)
- Figure 4-78: Pressure Guidewire Comparison
- Figure 4-79: Carotid Artery Implant for Preventing Stroke in Atrial Fibrillation Patients Taking Oral Anticoagulants (CAPTURE2)
- Figure 4-80: transShield Embolic Protection System Feasibility Study
- Figure 4-81: The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
- Figure 4-82: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
- Figure 4-83: The Prospective Segeberg Registry for Rotational Atherectomy in Coronary Lesion/s
- Figure 4-84: Coronary Atherectomy System in Patients With Coronary Calcification (CORECT)
- Figure 4-85: Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions (ROTA-CUT)
- Figure 4-86: Multicenter Study to Evaluate the Procedural Safety and Efficacy of ELCA in CAD (ELCA-CAD)
- Figure 4-87: VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial
- Figure 4-88: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation (Style-AF)
- Figure 4-89: Application of Vascular Closure Device in Transvenous Cardiac Intervention
- Figure 4-90: Comparison of Different Vascular Closure Device in TAVI
- Figure 4-91: Angio-seal VIP Versus Perclose ProGlide for Closure of the Femoral Artery in Peripheral Vascular Disease
- Figure 4-92: Real World Use and Outcomes of VASCADE Closure Device Versus Manual Compression in Patients With CFA Disease (VASCADE)
- Figure 4-93: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
- Figure 4-94: Vascular Closure Device in Transcatheter Aortic Valve Replacement
- Figure 4-95: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
- Figure 4-96: Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES)
- Figure 4-97: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
- Figure 4-98: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
- Figure 4-99: The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) (OCTOBER)
- Figure 4-100: Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (OCTIVUS)
- Figure 4-101: Intravascular Ultrasound Guidance for Complex High-Risk Indicated Procedures (IVUS-CHIP)
- Figure 4-102: The OPTIMAL Randomized Controlled Trial
- Figure 4-103: IVUS VS CAG Guided PCI for Patients With LMB Lesion (Infinite)
- Figure 4-104: Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation (GUIDE DES)
- Figure 4-105: Clinical Evaluation of a New High-speed and High-Resolution Intravascular Ultrasound System (NEW-IVUS)
- Figure 4-106: Optical Coherence Tomography of the Saphenous Vein Graft (OCTOCAB)
- Figure 4-107: Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography
- Figure 4-108: Does OCT Optimise Results of Stenting on the Left Main Stem (DOCTORS-LM)
- Figure 4-109: Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
- Figure 5-1: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (1 of 2)
- Figure 5-2: Interventional Cardiology Market by Segment, Global, 2019 – 2029 (US$M) (2 of 2)
- Figure 5-3: Interventional Cardiology Market by Region, Global, 2019 – 2029 (US$M)
- Figure 5-4: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (1 of 2)
- Figure 5-5: Leading Competitors, Interventional Cardiology Market by Segment, Global, 2022 (2 of 2)
- Figure 5-6: SWOT Analysis, Abbott (1 of 2)
- Figure 5-7: SWOT Analysis, Abbott (2 of 2)
- Figure 5-8: SWOT Analysis, Asahi Intecc
- Figure 5-9: SWOT Analysis, Boston Scientific
- Figure 5-10: SWOT Analysis, Cordis
- Figure 5-11: SWOT Analysis, Cook Medical
- Figure 5-12: SWOT Analysis, Medtronic
- Figure 5-13: SWOT Analysis, Penumbra
- Figure 5-14: SWOT Analysis, Philips
- Figure 5-15: SWOT Analysis, Teleflex
- Figure 5-16: SWOT Analysis, Terumo
- Figure 6-1: Coronary Stent Procedures Covered
- Figure 6-2: Coronary Stent Markets Covered
- Figure 6-3: Coronary Stent Regions Covered, Global (1 of 2)
- Figure 6-4: Coronary Stent Regions Covered, Global (2 of 2)
- Figure 6-5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
- Figure 6-6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029
- Figure 6-7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
- Figure 6-8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
- Figure 6-9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029
- Figure 6-10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
- Figure 6-11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
- Figure 6-12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029
- Figure 6-13: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3)
- Figure 6-14: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3)
- Figure 6-15: Angioplasty/PCI Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3)
- Figure 6-16: Angioplasty/PCI Procedures by Country, Africa, 2019 – 2029
- Figure 6-17: Coronary Stent Market by Segment, Global, 2019 – 2029 (US$M)
- Figure 6-18: Coronary Stent Market by Region, Global, 2019 – 2029 (US$M)
- Figure 6-19: Total Coronary Stent Market, Global, 2019 – 2029
- Figure 6-20: Units Sold by Region, Coronary Stent Market, Global, 2019 – 2029
- Figure 6-21: Average Selling Price by Region, Coronary Stent Market, Global, 2019 – 2029 (US$)
- Figure 6-22: Market Value by Region, Coronary Stent Market, Global, 2019 – 2029 (US$M)
- Figure 6-23: Bare-Metal Stent Market, Global, 2019 – 2029
- Figure 6-24: Units Sold by Region, Bare-Metal Stent Market, Global, 2019 – 2029
- Figure 6-25: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$)
- Figure 6-26: Market Value by Region, Bare-Metal Stent Market, Global, 2019 – 2029 (US$M)
- Figure 6-27: Drug-Eluting Stent Market, Global, 2019 – 2029
- Figure 6-28: Units Sold by Region, Drug-Eluting Stent Market, Global, 2019 – 2029
- Figure 6-29: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$)
- Figure 6-30: Market Value by Region, Drug-Eluting Stent Market, Global, 2019 – 2029 (US$M)
- Figure 6-31: Leading Competitors, Coronary Stent Market, Global, 2022
- Figure 7-1: Coronary Balloon Catheter Procedures Covered
- Figure 7-2: Coronary Balloon Catheter Markets Covered
- Figure 7-3: Coronary Balloon Catheter Regions Covered, Global (1 of 2)
- Figure 7-4: Coronary Balloon Catheter Regions Covered, Global (2 of 2)
- Figure 7-5: Total Angioplasty/PCI Procedures by Region, Global, 2019 – 2029
- Figure 7-6: Angioplasty/PCI Procedures by Country, North America, 2019 – 2029
- Figure 7-7: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (1 of 2)
- Figure 7-8: Angioplasty/PCI Procedures by Country, Latin America, 2019 – 2029 (2 of 2)
- Figure 7-9: Angioplasty/PCI Procedures by Country, Western Europe, 2019 – 2029
- Figure 7-10: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2)
- Figure 7-11: Angioplasty/PCI Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2)
- Figure 7-12: Angioplasty/PCI Procedures by Country, Middle East, 2019 – 2029
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
